#checkpoint_inhibition — Sunday, March 01, 2026 (1 items)
| 0 | 💬 0 |
Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.
(nature.com)
|
Nature Medicine 2026-03-01 | #pharmacokinetics #cancer #immunotherapy #biomarker #checkpoint_inhibition |